OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of m6A Ribonucleic Acid Modification in the Occurrence of Atherosclerosis
Jie Fu, Xinghui Cui, Xiaoyun Zhang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 25
Jie Fu, Xinghui Cui, Xiaoyun Zhang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 25
Showing 25 citing articles:
Exercise Mitigates Endothelial Pyroptosis and Atherosclerosis by Downregulating NEAT1 Through N6-Methyladenosine Modifications
Qingyuan Yang, Shiliang Chen, Xingyi Wang, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 6, pp. 910-926
Open Access | Times Cited: 52
Qingyuan Yang, Shiliang Chen, Xingyi Wang, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 6, pp. 910-926
Open Access | Times Cited: 52
METTL14/YTHDF1 axis-modified UCHL5 aggravates atherosclerosis by activating the NLRP3 inflammasome
Xiaohu Yang, Chen Wang, Guanglang Zhu, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 2, pp. 113587-113587
Closed Access | Times Cited: 16
Xiaohu Yang, Chen Wang, Guanglang Zhu, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 2, pp. 113587-113587
Closed Access | Times Cited: 16
ALKBH5 inhibits TNF-α-induced apoptosis of HUVECs through Bcl-2 pathway
Xiaoshan Zhang, Shibing Deng, Peng Yang, et al.
Open Medicine (2022) Vol. 17, Iss. 1, pp. 1092-1099
Open Access | Times Cited: 18
Xiaoshan Zhang, Shibing Deng, Peng Yang, et al.
Open Medicine (2022) Vol. 17, Iss. 1, pp. 1092-1099
Open Access | Times Cited: 18
Peli1, regulated by m6A modification, suppresses NLRP3 inflammasome activation in atherosclerosis by inhibiting YB-1
Qiang Liu, Yan Lü, Tao Wu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Qiang Liu, Yan Lü, Tao Wu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Epigenetic Regulation in Pathology of Atherosclerosis: A Novel Perspective
Haishuang Tang, Zhangwei Zeng, Chenghao Shang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 23
Haishuang Tang, Zhangwei Zeng, Chenghao Shang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 23
METTL3 confers protection against mitochondrial dysfunction and cognitive impairment in an Alzheimer disease mouse model by upregulating Mfn2 via N6-methyladenosine modification
H Chen, Huaijie Xing, Changhui Zhong, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 7, pp. 606-614
Closed Access | Times Cited: 3
H Chen, Huaijie Xing, Changhui Zhong, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 7, pp. 606-614
Closed Access | Times Cited: 3
Stress Granules in Atherosclerosis: Insights and Therapeutic Opportunities
Sahar Naseem, Lijuan Sun, Juhui Qiu
Current Problems in Cardiology (2024) Vol. 49, Iss. 10, pp. 102760-102760
Closed Access | Times Cited: 2
Sahar Naseem, Lijuan Sun, Juhui Qiu
Current Problems in Cardiology (2024) Vol. 49, Iss. 10, pp. 102760-102760
Closed Access | Times Cited: 2
Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation
Hao Liang, Chengyuan Fang, Luquan Zhang
AJP Cell Physiology (2023) Vol. 325, Iss. 3, pp. C770-C779
Closed Access | Times Cited: 5
Hao Liang, Chengyuan Fang, Luquan Zhang
AJP Cell Physiology (2023) Vol. 325, Iss. 3, pp. C770-C779
Closed Access | Times Cited: 5
Transcriptome-wide N6-methyladenosine methylation profile of atherosclerosis in mice
Xinbin Zheng, Bo Zhou, Yuzhen Li, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Xinbin Zheng, Bo Zhou, Yuzhen Li, et al.
BMC Genomics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
N6-Methyladenosine in Vascular Aging and Related Diseases: Clinical Perspectives
Chen Li, Le Liu, Shuang Li, et al.
Aging and Disease (2023)
Open Access | Times Cited: 4
Chen Li, Le Liu, Shuang Li, et al.
Aging and Disease (2023)
Open Access | Times Cited: 4
Screening of m6A-associated ferroptosis-related genes in atherosclerosis based on WGCNA
Meiling Jiang, Weidong Zhao, Liyong Wu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Meiling Jiang, Weidong Zhao, Liyong Wu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Site‐specific m6A‐miR‐494‐3p, not unmethylated miR‐494‐3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis
Tamar Woudenberg, M. Leontien van der Bent, Veerle Kremer, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Tamar Woudenberg, M. Leontien van der Bent, Veerle Kremer, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
N6-methyladenosine (m6A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose
Zhenjin Li, Xuying Meng, Yu Chen, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13721-e13721
Open Access | Times Cited: 3
Zhenjin Li, Xuying Meng, Yu Chen, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e13721-e13721
Open Access | Times Cited: 3
Potential Impact of N6-Methyladenosine RNA Methylation on Vision Function and the Pathological Processes of Ocular Diseases: New Discoveries and Future Perspectives
Xiaohua Li, Binyun Ma, Mengyu Liao, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 7, pp. 207-207
Open Access | Times Cited: 5
Xiaohua Li, Binyun Ma, Mengyu Liao, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 7, pp. 207-207
Open Access | Times Cited: 5
Proteomics Studies Suggest That Nitric Oxide Donor Furoxans Inhibit In Vitro Vascular Smooth Muscle Cell Proliferation by Nitric Oxide-Independent Mechanisms
Loretta Lazzarato, Laura Bianchi, Annapaola Andolfo, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5724-5724
Open Access | Times Cited: 2
Loretta Lazzarato, Laura Bianchi, Annapaola Andolfo, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5724-5724
Open Access | Times Cited: 2
Detection techniques for epitranscriptomic marks
Ken Ofusa, Ryota Chijimatsu, Hideshi Ishii
AJP Cell Physiology (2022) Vol. 322, Iss. 4, pp. C787-C793
Closed Access | Times Cited: 3
Ken Ofusa, Ryota Chijimatsu, Hideshi Ishii
AJP Cell Physiology (2022) Vol. 322, Iss. 4, pp. C787-C793
Closed Access | Times Cited: 3
m6A ‘writer’ KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis
Jian Rong, Yingxin Jie, Hui Zhao
Molecular Biotechnology (2022) Vol. 65, Iss. 7, pp. 1198-1206
Open Access | Times Cited: 3
Jian Rong, Yingxin Jie, Hui Zhao
Molecular Biotechnology (2022) Vol. 65, Iss. 7, pp. 1198-1206
Open Access | Times Cited: 3
KLF7 reverses ox-LDL-induced ferroptosis in HMEC-1 cells through transcriptionally activating ALKBH5 to inhibit the m6A modification of ACSL4
Qinggen Xiong, Zhijian Luo, Xiaoming Xie, et al.
Cytotechnology (2024) Vol. 76, Iss. 6, pp. 653-666
Closed Access
Qinggen Xiong, Zhijian Luo, Xiaoming Xie, et al.
Cytotechnology (2024) Vol. 76, Iss. 6, pp. 653-666
Closed Access
The role of m6A modification in cardiovascular disease: A systematic review and integrative analysis
Xu-Man Feng, Yu Zhang, Ning Chen, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113603-113603
Closed Access
Xu-Man Feng, Yu Zhang, Ning Chen, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113603-113603
Closed Access
Mechanisms of METTL14‐Mediated m6A Modification in Promoting Iron Overload‐Induced Lipid Peroxidative Damage in Vascular Endothelial Cells to Aggravate Atherosclerosis
Xiaoli Min, Song Lin, Xiao‐hong Zhao, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Open Access
Xiaoli Min, Song Lin, Xiao‐hong Zhao, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Open Access
Clinical significance of the m6A methyltransferase METTL3 in peripheral blood of patients with coronary heart disease
Jianshe Chang, R. Shao, Xiangshan Xu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Jianshe Chang, R. Shao, Xiangshan Xu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
N6-methyladenosine (m6A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose
Zhenjin Li, Xuying Meng, Yu Chen, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 2
Zhenjin Li, Xuying Meng, Yu Chen, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 2
N6-methyladenosine writer KIAA1429 modulates the proliferation/migration of endothelial cells for atherosclerosis
Jian Rong, Yingxin Jie, Hui Zhao
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Jian Rong, Yingxin Jie, Hui Zhao
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
RNA modification by M6A methylation in cardiovascular diseases: Current trends and future directions
Jinglin Wang, Lingfeng Zha
Frigid Zone Medicine (2022) Vol. 2, Iss. 3, pp. 158-177
Open Access | Times Cited: 1
Jinglin Wang, Lingfeng Zha
Frigid Zone Medicine (2022) Vol. 2, Iss. 3, pp. 158-177
Open Access | Times Cited: 1
Peli1, regulated by m 6 A modification, suppresses atherosclerosis progression by inhibiting YB-1-mediated NLRP3 inflammasome activation
Qiang Liu, Yan Lü, Tao Wu, et al.
Research Square (Research Square) (2023)
Open Access
Qiang Liu, Yan Lü, Tao Wu, et al.
Research Square (Research Square) (2023)
Open Access
